August 2013 FDA Recall Drug by Marlex Pharmaceuticals, Inc.
D-1064-2013 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Marlex Pharmaceuticals, Inc. on August 8, 2013 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1064-2013

Reason for Recall
CGMP Deviations: The recalled acetaminophen tablet lot was not manufactured under current good manufacturing practices as noted by a recent inspection of the manufacturing firm.
Initiated
08-08-2013
Reported
10-09-2013
Quantity
28,387 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Marlex Pharmaceuticals, Inc.
Acetaminophen Tablets, 500 mg, 100-count bottles, Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, List No. 152, NDC 10135-152-01, UPC 3 10135 15201 8.

Batch or Lot Expiration Information

Lot# : 3213, Exp 12/13